Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Zika Virus | 7 | 2020 | 1924 | 1.05 | Why? |
| Zika Virus Infection | 5 | 2019 | 1920 | 0.90 | Why? |
| Islets of Langerhans | 1 | 2021 | 138 | 0.79 | Why? |
| alpha 1-Antitrypsin | 2 | 2021 | 264 | 0.76 | Why? |
| Peptide Fragments | 2 | 2020 | 2075 | 0.74 | Why? |
| HIV Fusion Inhibitors | 1 | 2018 | 80 | 0.70 | Why? |
| HIV Envelope Protein gp41 | 1 | 2018 | 153 | 0.67 | Why? |
| Milk, Human | 4 | 2020 | 956 | 0.66 | Why? |
| Sexually Transmitted Diseases, Viral | 1 | 2018 | 115 | 0.63 | Why? |
| Genetic Fitness | 1 | 2018 | 339 | 0.62 | Why? |
| Colorimetry | 2 | 2018 | 458 | 0.54 | Why? |
| Semen | 1 | 2018 | 550 | 0.48 | Why? |
| Virus Attachment | 2 | 2021 | 1259 | 0.45 | Why? |
| Bridged-Ring Compounds | 2 | 2020 | 45 | 0.39 | Why? |
| Organophosphates | 2 | 2020 | 66 | 0.38 | Why? |
| High-Throughput Screening Assays | 1 | 2017 | 1783 | 0.34 | Why? |
| HIV-1 | 3 | 2020 | 3365 | 0.33 | Why? |
| Serine Proteinase Inhibitors | 2 | 2021 | 341 | 0.32 | Why? |
| Antiviral Agents | 10 | 2021 | 41703 | 0.31 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.29 | Why? |
| RNA-Binding Proteins | 2 | 2021 | 1022 | 0.25 | Why? |
| Fibroblasts | 2 | 2018 | 839 | 0.25 | Why? |
| Vero Cells | 8 | 2021 | 14117 | 0.25 | Why? |
| Serine Endopeptidases | 4 | 2021 | 4606 | 0.23 | Why? |
| Pancreas, Exocrine | 1 | 2021 | 51 | 0.22 | Why? |
| Ebolavirus | 2 | 2018 | 834 | 0.21 | Why? |
| Herpesvirus 2, Human | 1 | 2021 | 137 | 0.21 | Why? |
| Pasteurization | 1 | 2020 | 102 | 0.20 | Why? |
| Carrageenan | 1 | 2021 | 123 | 0.20 | Why? |
| Antigens, Differentiation | 1 | 2021 | 172 | 0.20 | Why? |
| Breast Feeding | 2 | 2020 | 1585 | 0.20 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2021 | 159 | 0.20 | Why? |
| CpG Islands | 1 | 2020 | 230 | 0.19 | Why? |
| Human Embryonic Stem Cells | 1 | 2020 | 199 | 0.19 | Why? |
| Viral Plaque Assay | 1 | 2020 | 381 | 0.18 | Why? |
| Virus Replication | 7 | 2021 | 14331 | 0.18 | Why? |
| Pancreatic Diseases | 1 | 2021 | 191 | 0.18 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.17 | Why? |
| Genitalia | 1 | 2018 | 98 | 0.17 | Why? |
| Receptors, CCR5 | 1 | 2018 | 186 | 0.16 | Why? |
| Primary Cell Culture | 1 | 2018 | 501 | 0.16 | Why? |
| Benchmarking | 1 | 2020 | 627 | 0.16 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.16 | Why? |
| Protein Structure, Secondary | 1 | 2020 | 1077 | 0.16 | Why? |
| Protein Structure, Tertiary | 1 | 2020 | 1565 | 0.15 | Why? |
| Mouthwashes | 1 | 2020 | 432 | 0.15 | Why? |
| Cell Survival | 2 | 2021 | 1581 | 0.15 | Why? |
| Inhibitory Concentration 50 | 1 | 2018 | 907 | 0.14 | Why? |
| Intestinal Mucosa | 2 | 2020 | 1046 | 0.14 | Why? |
| Amino Acid Sequence | 3 | 2021 | 6049 | 0.14 | Why? |
| Mucous Membrane | 1 | 2017 | 305 | 0.14 | Why? |
| Organoids | 1 | 2020 | 840 | 0.13 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.13 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2021 | 1115 | 0.12 | Why? |
| Polymers | 1 | 2017 | 507 | 0.12 | Why? |
| Cell Line | 5 | 2021 | 12040 | 0.12 | Why? |
| Caco-2 Cells | 3 | 2021 | 1236 | 0.12 | Why? |
| Virus Internalization | 3 | 2021 | 7921 | 0.12 | Why? |
| Immune Sera | 1 | 2017 | 884 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| Animals | 10 | 2021 | 78931 | 0.11 | Why? |
| Extracellular Vesicles | 1 | 2018 | 607 | 0.11 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.11 | Why? |
| Drug Delivery Systems | 1 | 2020 | 1365 | 0.11 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.10 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.10 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.10 | Why? |
| Temperature | 1 | 2019 | 2305 | 0.10 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.09 | Why? |
| Interferon-alpha | 1 | 2017 | 1442 | 0.09 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.09 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.09 | Why? |
| HEK293 Cells | 2 | 2018 | 8394 | 0.09 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.08 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.08 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.08 | Why? |
| Humans | 26 | 2021 | 930598 | 0.08 | Why? |
| RNA, Viral | 4 | 2020 | 32276 | 0.07 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
| Viral Load | 3 | 2020 | 15850 | 0.07 | Why? |
| HIV Infections | 3 | 2020 | 11620 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.06 | Why? |
| Neutralization Tests | 1 | 2017 | 6698 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Female | 11 | 2021 | 380317 | 0.06 | Why? |
| Seminal Vesicle Secretory Proteins | 1 | 2020 | 32 | 0.06 | Why? |
| Acid Phosphatase | 1 | 2020 | 35 | 0.06 | Why? |
| Oral Sprays | 1 | 2021 | 92 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Endopeptidase K | 1 | 2020 | 71 | 0.05 | Why? |
| Lysine | 1 | 2020 | 153 | 0.05 | Why? |
| Heating | 1 | 2020 | 100 | 0.05 | Why? |
| Gram-Positive Bacteria | 1 | 2021 | 230 | 0.05 | Why? |
| Amyloid | 1 | 2020 | 156 | 0.05 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.05 | Why? |
| Dimerization | 1 | 2021 | 475 | 0.05 | Why? |
| Candida albicans | 1 | 2021 | 217 | 0.05 | Why? |
| Protein Isoforms | 1 | 2020 | 347 | 0.05 | Why? |
| Anti-Bacterial Agents | 1 | 2021 | 10083 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Nasal Sprays | 1 | 2021 | 234 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Sequence Homology, Amino Acid | 1 | 2021 | 945 | 0.05 | Why? |
| Foreskin | 1 | 2017 | 4 | 0.04 | Why? |
| Arginine | 1 | 2020 | 377 | 0.04 | Why? |
| Urethra | 1 | 2017 | 47 | 0.04 | Why? |
| Endometrium | 1 | 2017 | 68 | 0.04 | Why? |
| RNA, Small Interfering | 1 | 2021 | 817 | 0.04 | Why? |
| Coculture Techniques | 1 | 2017 | 258 | 0.04 | Why? |
| Gram-Negative Bacteria | 1 | 2021 | 473 | 0.04 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 343 | 0.04 | Why? |
| Cell Membrane | 1 | 2020 | 743 | 0.04 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2020 | 881 | 0.04 | Why? |
| Interferon-beta | 1 | 2021 | 979 | 0.04 | Why? |
| Sequence Alignment | 1 | 2021 | 2109 | 0.04 | Why? |
| Male | 6 | 2021 | 367725 | 0.03 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.03 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2020 | 1647 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2021 | 2134 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2020 | 2219 | 0.03 | Why? |
| SARS Virus | 1 | 2017 | 13021 | 0.03 | Why? |
| Lipids | 1 | 2020 | 1079 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2021 | 2886 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Intention | 1 | 2020 | 1380 | 0.03 | Why? |
| Nigeria | 1 | 2018 | 2292 | 0.03 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.03 | Why? |
| Mothers | 1 | 2020 | 1624 | 0.03 | Why? |
| Blood Platelets | 1 | 2021 | 1704 | 0.03 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.03 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.02 | Why? |
| Adult | 4 | 2021 | 244371 | 0.02 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2021 | 4020 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.02 | Why? |
| Anti-HIV Agents | 1 | 2020 | 2209 | 0.02 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2018 | 1475 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2021 | 6902 | 0.02 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.02 | Why? |
| Aged | 1 | 2021 | 215776 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2018 | 10017 | 0.01 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2018 | 9091 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
Müller's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(164)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(191)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_